Loading...
Rheumatic disease and COVID-19: epidemiology and outcomes
Since the outset of the COVID-19 pandemic, numerous risk factors for severe disease have been identified. Whether patients with rheumatic diseases, especially those receiving DMARDs, are at an increased risk of SARS-CoV-2 infection or severe COVID-19 disease remains unclear, although epidemiological...
Na minha lista:
| Udgivet i: | Nat Rev Rheumatol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747184/ https://ncbi.nlm.nih.gov/pubmed/33339986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41584-020-00562-2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|